Abstract
The decision to operate on a medically stable patient with primary hyperparathyroidism is based on the risk of the patient to develop complications due to persistent hypercalcaemia, compared to the risks and complications associated with the surgery. The severity of hypercalcaemia is an important determinant in the decision to perform surgery. Although there is no absolute level of serum calcium which provides a clear-cut criteria for surgery, most endocrinologists and surgeons consider serum calcium level of 11.5 mg/dL or greater as an absolute indication for surgery (Kenny et al. 1995). In 85% to 90% of patients, hyperparathyroidism occurs as a result of a single adenoma. Exploration and removal of the adenoma are curative in greater than 95% of patients, and the long-term benefit and potential for cure are high (Bruining et al. 1987).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bilezikian JP, Khan AA, Potts JT Jr. Third international workshop on the management of asymptomatic primary hyperthyroidism. J Clin Endocrinol Metab. 2009;94(2):335–9.
Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9.
Bonjer HJ, Bruining HA, Birkenhager JC, et al. Single and multigland disease in primary hyperparathyroidism: clinical followup, histopathology, and flow cytometric DNA analysis. World J Surg. 1992;16:737–44.
Bruining H, Brikenhager J, Ong G, et al. Causes of failure in operation for hyperparathyroidism. Surgery. 1987;101:562–5.
Howe JR. Minimally invasive parathyroid surgery. Surg Clin North Am. 2000;80:1399–426.
Irvin GL, Deriso GT. A new, practical intraoperative parathyroid hormone assay. Am J Surg. 1994;168:466–8.
Irvin GL, Prudhomme DL, Derisio GT, et al. A new approach to parathyroidectomy. Ann Surg. 1994;219:574–81.
Kao PC, van Heerden JA, Taylor RL. Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clin Proc. 1994;69:532–7.
Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg. 1992;215:300–16.
Kenny A, MacGillivray D, Pilbeam C, et al. Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery. 1995;118:109–14.
Malmaeus J, Granberg P, Halvorsen J, et al. Parathyroid surgery in Scandinavia. Acta Chir Scand. 1988;154:409–20.
National Institutes of Health Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med. 1991;114:593–7.
National Institutes of Health Conference. Asymptomatic primary hyperparathyroidism. Washington, DC: National Institutes of Health Conference; 2002.
Nussbaum SR, Thompson AR, Hutcheson KA, et al. Intraoperative measurement of parathyroid hormone in the surgical management of hyperparathyroidism. Surgery. 1988;104:1221–7.
Patel PC, Pellitteri PK, Patel NM, et al. Use of a rapid intraoperative parathyroid hormone assay in the surgical management of parathyroid disease. Arch Otolaryngol Head Neck Surg. 1998;124:559–62.
Proye CAG, Carnaille B, Bizard JP, et al. Single and multigland disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the 1990s? A plea against unilateral parathyroid exploration. Surgery. 1992;112:1118–21.
Shaha AR, Jaffe BM. Cervical exploration for primary hyperparathyroidism. J Surg Oncol. 1993;52:14–7.
Shen W, Düren M, Morita E, Higgins C, Duh QY, Siperstein AE, Clark OH. Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg. 1996;131(8):861–7; discussion 867–9.
Weber CJ, Sewell CW, McGarity WC. Persistent and recurrent sporadic primary hyperparathyroidism: histopathology, complications, and results of reoperation. Surgery. 1994;116:991–8.
Wong KK, Fig LM, Gross MD, Dwamena BA. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun. 2015;36(4):363–75.
Acknowledgements
The authors sincerely acknowledge the contributions of Dr. Karan Gupta, Head and Neck Surgeon Medanta Medicity, for supporting in writing the surgical perspectives of parathyroid surgery. I am also extremely grateful to the entire head and neck oncosurgery and ENT department for their constant guidance and postoperative feedbacks, always inspiring me to explore more possibilities of accurate preoperative diagnosis, aiming to give the highest level of information to the surgeon, ease of localization of the abnormal parathyroids at surgery and support in patient care and management.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Singhal, A.A. (2023). Essentials of Surgical Perspectives of Parathyroid Surgery. In: Atlas of Sonography of Parathyroid. Springer, Singapore. https://doi.org/10.1007/978-981-19-7919-4_12
Download citation
DOI: https://doi.org/10.1007/978-981-19-7919-4_12
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-7918-7
Online ISBN: 978-981-19-7919-4
eBook Packages: MedicineMedicine (R0)